AR026637A1 - Virus atenuados e inocuos de la diarrea virica bovina para uso en vacas gestantes - Google Patents
Virus atenuados e inocuos de la diarrea virica bovina para uso en vacas gestantesInfo
- Publication number
- AR026637A1 AR026637A1 ARP000106270A ARP000106270A AR026637A1 AR 026637 A1 AR026637 A1 AR 026637A1 AR P000106270 A ARP000106270 A AR P000106270A AR P000106270 A ARP000106270 A AR P000106270A AR 026637 A1 AR026637 A1 AR 026637A1
- Authority
- AR
- Argentina
- Prior art keywords
- diarrhea
- virica
- innocus
- bovina
- viruses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Suspension/Interruption
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/544—Mucosal route to the airways
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
- C12N2770/24361—Methods of inactivation or attenuation
- C12N2770/24362—Methods of inactivation or attenuation by genetic engineering
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/82—Proteins from microorganisms
- Y10S530/826—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Se refiere al uso de virus BVD (diarrea vírica bovina) vivos y específicamente atenuados, para la preparacion de una vacuna para uso en la prevencion y/otratamiento de infecciones BVDV en ganado vacuno reproductor, vacas gestantes y para la proteccio n fetal en vacas gestantes.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99123767A EP1104676A1 (en) | 1999-11-30 | 1999-11-30 | Safe attenuated bovine viral diarrhea viruses for use in pregnant cows |
Publications (1)
Publication Number | Publication Date |
---|---|
AR026637A1 true AR026637A1 (es) | 2003-02-19 |
Family
ID=8239496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000106270A Suspension/Interruption AR026637A1 (es) | 1999-11-30 | 2000-11-29 | Virus atenuados e inocuos de la diarrea virica bovina para uso en vacas gestantes |
Country Status (10)
Country | Link |
---|---|
US (1) | US6610305B1 (es) |
EP (2) | EP1104676A1 (es) |
AR (1) | AR026637A1 (es) |
AU (1) | AU777991B2 (es) |
CA (1) | CA2388678A1 (es) |
CO (1) | CO5280138A1 (es) |
MX (1) | MXPA02004236A (es) |
NZ (1) | NZ519786A (es) |
UY (1) | UY26450A1 (es) |
WO (1) | WO2001039801A2 (es) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7179473B2 (en) * | 1998-06-05 | 2007-02-20 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
US6168942B1 (en) | 1998-11-10 | 2001-01-02 | Pfizer Inc. | Attenuated forms of bovine viral diarrhea virus |
DE10143813A1 (de) * | 2001-09-06 | 2003-04-10 | Boehringer Ingelheim Vetmed | Infektiöser Rindervirusdiarrhoe-Virusklon |
US7135561B2 (en) | 2001-09-06 | 2006-11-14 | Boehringer Ingelheim Vetmedica Gmbh | Infectious bovine viral diarrhea virus clone |
AU2003258611A1 (en) * | 2002-08-13 | 2004-03-03 | Akzo Nobel N.V. | Replicons of pestiviruses that do not express c and or e1 protein and infectious viral particles containing same, that can be used in vaccines |
DE102004025452A1 (de) * | 2004-05-19 | 2006-01-19 | Boehringer Ingelheim Vetmedica Gmbh | Vakzine enthaltend BVDV |
US7572455B2 (en) * | 2004-05-19 | 2009-08-11 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine comprising an attenuated pestivirus |
UY29915A1 (es) * | 2005-11-15 | 2007-06-29 | Boehringer Ingelheim Vetmed | Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina |
UA105362C2 (en) | 2008-04-02 | 2014-05-12 | Бьорингер Ингельхайм Интернациональ Гмбх | 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators |
UY31930A (es) * | 2008-06-25 | 2010-01-29 | Boheringer Ingelheim Pharma Kg | Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante |
US8846054B2 (en) * | 2009-01-09 | 2014-09-30 | Boehringer Ingelheim Vetmedica, Inc. | Method of treating pregnant cows and/or heifers |
EP2618841B1 (en) | 2010-09-21 | 2016-10-19 | Intervet International B.V. | Bvdv vaccine |
AR084358A1 (es) * | 2010-12-27 | 2013-05-08 | Lilly Co Eli | Composiciones y metodos para identificar y diferenciar componentes virales de vacunas multivalentes de la “fiebre de embarque” (complejo de enfermedad respiratoria bovina (brdc)) |
WO2020046857A1 (en) * | 2018-08-27 | 2020-03-05 | Vanderbilt University | Human monoclonal antibodies that neutralize pandemic gii.4 noroviruses |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU688819B2 (en) * | 1993-11-05 | 1998-03-19 | Bayer Aktiengesellschaft | Viral vector with bovine viral diarrhea virus (BVDV) antigens |
EP0965639A1 (en) * | 1998-06-05 | 1999-12-22 | Boehringer Ingelheim Vetmedica Gmbh | Attenuated pestiviruses |
-
1999
- 1999-11-30 EP EP99123767A patent/EP1104676A1/en not_active Withdrawn
-
2000
- 2000-11-06 US US09/706,649 patent/US6610305B1/en not_active Expired - Lifetime
- 2000-11-27 UY UY26450A patent/UY26450A1/es not_active Application Discontinuation
- 2000-11-29 EP EP00988765A patent/EP1237572A2/en not_active Withdrawn
- 2000-11-29 CO CO00091439A patent/CO5280138A1/es not_active Application Discontinuation
- 2000-11-29 NZ NZ519786A patent/NZ519786A/en not_active IP Right Cessation
- 2000-11-29 WO PCT/EP2000/011940 patent/WO2001039801A2/en active IP Right Grant
- 2000-11-29 AR ARP000106270A patent/AR026637A1/es not_active Suspension/Interruption
- 2000-11-29 AU AU25091/01A patent/AU777991B2/en not_active Expired
- 2000-11-29 CA CA002388678A patent/CA2388678A1/en not_active Abandoned
- 2000-11-29 MX MXPA02004236A patent/MXPA02004236A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
WO2001039801A2 (en) | 2001-06-07 |
UY26450A1 (es) | 2001-07-31 |
AU2509101A (en) | 2001-06-12 |
US6610305B1 (en) | 2003-08-26 |
CA2388678A1 (en) | 2001-06-07 |
MXPA02004236A (es) | 2003-01-28 |
CO5280138A1 (es) | 2003-05-30 |
WO2001039801A3 (en) | 2002-02-07 |
NZ519786A (en) | 2003-10-31 |
AU777991B2 (en) | 2004-11-11 |
EP1104676A1 (en) | 2001-06-06 |
EP1237572A2 (en) | 2002-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR026637A1 (es) | Virus atenuados e inocuos de la diarrea virica bovina para uso en vacas gestantes | |
EA200500275A1 (ru) | Вакцина против инфекций респираторной и репродуктивной систем крупного рогатого скота | |
TR199903053T2 (xx) | Benzimidazol t�revleri. | |
WO2007117303A3 (en) | Combination vaccine comprising an attenuated bovine viral diarrhea virus | |
TR200002965T2 (tr) | Enfeksiyonların terapötik ve profilaktik tedavisi için organofosforlu terkiplerin kullanımı | |
CO5611162A2 (es) | Metodos para prevenir enfermedades reproductivas en el ganado vacuno | |
ZA964694B (en) | Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection. | |
ECSP045102A (es) | Formulación farmacéutica que contiene 3-(3-dimetilamino-1-etil-2-metil-propil)fenol y proporciona una liberación retardada del ingrediente activo | |
AU7501898A (en) | Live attenuated virus vaccines for equine encephalitis viruses | |
MX9603896A (es) | Vacuna para la prevencion de enfermedades respiratorias y reproductivas del cerdo, que contiene virus parainfluenza. | |
PT957935E (pt) | Vacinas e composicoes imunogenicas contra clamidia contendo um antigenio de membrana externa e metodos para a sua preparacao | |
PE20001338A1 (es) | Uso de interleuquina 10 para el tratamiento de infecciones causadas por el virus de la hepatitis c | |
RU93056144A (ru) | Способ инактивации вирусов в оболочке, способ ингибирования активности спермы, противозачаточное средство, средство для вытирания | |
WO2002013855A3 (en) | Vaccines containing ribavirin and methods of use thereof | |
PT1242119E (pt) | Combinacoes para o tratamento de infeccoes por virus adn incluindo um diuretico de ansa e um glicosido cardiotonico | |
HUP9901958A2 (hu) | Sertés reproduktív és respirációs szindróma vakcina | |
ZA964679B (en) | Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection. | |
BR0212312A (pt) | Clone infeccioso do vìrus da diarréia viral bovina | |
AR022250A1 (es) | Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b. | |
NO912271L (no) | Somatostatinpreparater, deres fremstilling og anvendelse. | |
DK1372712T3 (da) | Vaccine mod equint herpesvirus | |
AR016987A1 (es) | Composiciones acuosas de vacuna acuosaa para la profilaxis de hepatitis b o hepatitis b/a | |
BR0108735A (pt) | Proteção in ovo contra bronquite infecciosa | |
TH62362A (th) | ไวรัสก่ออาการท้องร่วงจากไวรัสของโคที่ได้ทำให้อ่อนฤทธิ์โดยปลอดภัยสำหรับใช้ในโคที่ตั้งท้อง | |
KR920007636A (ko) | 신규의 백신체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |